The COVID-19 pandemic has forced countries to make difficult ethical choices, e.g., how to balance public health and socioeconomic activity and whom to prioritize in allocating vaccines or other scarc
NIPT, non-invasive prenatal testing * 70% of total affected pregnancies (30% receive no screening). † Assuming termination rates for trisomy 21, trisomy 18, trisomy 13, and monosomy X of 87%, 81%, 90%
